Vimarsana
Biggest News Aggregation in the World

Page 21 - Technologies Munich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technologies Munich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technologies Munich Today - Breaking & Trending Today

CNL Launches Program to Accelerate the Development of - Vimarsana News

CNL Launches Program to Accelerate the Development of

Canada’s national nuclear laboratory expands successful Canadian Nuclear Research Initiative to include health sciences stream...

CNL and Isotope Technologies Munich sign MoU on developing, producing 'rarest drug on Earth' - Vimarsana News

CNL and Isotope Technologies Munich sign MoU on developing, producing 'rarest drug on Earth'

CHALK RIVER — Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, announced on Oct. 18…

Isotope Technologies Munich SE: ITM and Clovis Oncology Announce Lutetium-177 Clinical Supply Agreement - Vimarsana News

Isotope Technologies Munich SE: ITM and Clovis Oncology Announce Lutetium-177 Clinical Supply Agreement

ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Clovis Oncology's Targeted Radionuclide Therapy candidate FAP-2286 ITM Isotope Technologies

Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement - Vimarsana News

Clovis Oncology and ITM Announce Lutetium-177 Clinical Supply Agreement

Clovis Oncology, Inc. (NASDAQ: CLVS) and ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, today announced the signing of a clinical supply agreement that provides

New isotope initiatives address supply challenges : Corporate - Vimarsana News

New isotope initiatives address supply challenges : Corporate

Separate domestic and international initiatives to support the development and production of medical radioisotopes have been announced in Canada, Germany, Japan and the USA. These include a federal award of USD35 million to support the commercial production of molybdenum-99 in the USA; a new linear accelerator-based technique for production of actinium-225 in Japan; and a Canadian-German collaboration to explore the production of Ac-225.